Log In
Print
BCIQ
Print
Print this Print this
 

OrbeShield (SGX202)

  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionOral formulation of beclomethasone dipropionate (BDP) consisting of one tablet intended to release BDP in the proximal portions of the GI tract and another to release BDP in the distal portions.
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationPoisoning
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today